To the Editor: The National Prescribing Service recently reviewed drug interaction information in a range of prescribing and dispensing software systems and reference sources, including the Therapeutic Goods Administration (TGA)-approved product information (PI). Our findings support those of Stockigt1 regarding the quality of information in PI.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.
We worked with an expert panel on this project: Professor Jo-anne Brien (Clinical and Academic Pharmacist), Dr Pradeep Jayasuriya (General Practitioner), Dr Jennifer Martin (Physician and Clinical Pharmacologist), and Mr Graeme Vernon (Drug Information Pharmacist).